160 related articles for article (PubMed ID: 19649566)
61. Analysis of the transcriptional regulation and molecular function of the aryl hydrocarbon receptor repressor in human cell lines.
Haarmann-Stemmann T; Bothe H; Kohli A; Sydlik U; Abel J; Fritsche E
Drug Metab Dispos; 2007 Dec; 35(12):2262-9. PubMed ID: 17890447
[TBL] [Abstract][Full Text] [Related]
62. An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling.
Pirone DM; Liu WF; Ruiz SA; Gao L; Raghavan S; Lemmon CA; Romer LH; Chen CS
J Cell Biol; 2006 Jul; 174(2):277-88. PubMed ID: 16847103
[TBL] [Abstract][Full Text] [Related]
63. Sequential activation of RhoA and FAK/paxillin leads to ATP release and actin reorganization in human endothelium.
Hirakawa M; Oike M; Karashima Y; Ito Y
J Physiol; 2004 Jul; 558(Pt 2):479-88. PubMed ID: 15155793
[TBL] [Abstract][Full Text] [Related]
64. Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway.
Oviedo PJ; Sobrino A; Laguna-Fernandez A; Novella S; Tarín JJ; García-Pérez MA; Sanchís J; Cano A; Hermenegildo C
Mol Cell Endocrinol; 2011 Mar; 335(2):96-103. PubMed ID: 20615453
[TBL] [Abstract][Full Text] [Related]
65. The Differential Selectivity of Aryl Hydrocarbon Receptor (AHR) Agonists towards AHR-Dependent Suppression of Mammosphere Formation and Gene Transcription in Human Breast Cancer Cells.
Saito N; Kanno Y; Yamashita N; Degawa M; Yoshinari K; Nemoto K
Biol Pharm Bull; 2021; 44(4):571-578. PubMed ID: 33790107
[TBL] [Abstract][Full Text] [Related]
66. Aromatic hydrocarbon receptor (AhR).AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells.
Mathieu MC; Lapierre I; Brault K; Raymond M
J Biol Chem; 2001 Feb; 276(7):4819-27. PubMed ID: 11096091
[TBL] [Abstract][Full Text] [Related]
67. G(i)-mediated Cas tyrosine phosphorylation in vascular endothelial cells stimulated with sphingosine 1-phosphate: possible involvement in cell motility enhancement in cooperation with Rho-mediated pathways.
Ohmori T; Yatomi Y; Okamoto H; Miura Y; Rile G; Satoh K; Ozaki Y
J Biol Chem; 2001 Feb; 276(7):5274-80. PubMed ID: 11056155
[TBL] [Abstract][Full Text] [Related]
68. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase.
Rousseau S; Houle F; Kotanides H; Witte L; Waltenberger J; Landry J; Huot J
J Biol Chem; 2000 Apr; 275(14):10661-72. PubMed ID: 10744763
[TBL] [Abstract][Full Text] [Related]
69. Pioglitazone reduces monocyte adhesion to vascular endothelium under flow by modulating RhoA GTPase and focal adhesion kinase.
Toriumi Y; Hiraoka M; Watanabe M; Yoshida M
FEBS Lett; 2003 Oct; 553(3):419-22. PubMed ID: 14572662
[TBL] [Abstract][Full Text] [Related]
70. RhoA and membrane fluidity mediates the spatially polarized Src/FAK activation in response to shear stress.
Liu B; Lu S; Hu YL; Liao X; Ouyang M; Wang Y
Sci Rep; 2014 Nov; 4():7008. PubMed ID: 25387906
[TBL] [Abstract][Full Text] [Related]
71. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
Madak-Erdogan Z; Katzenellenbogen BS
Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
[TBL] [Abstract][Full Text] [Related]
72. Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1.
Moss SC; Lightell DJ; Marx SO; Marks AR; Woods TC
J Biol Chem; 2010 Apr; 285(16):11991-7. PubMed ID: 20097763
[TBL] [Abstract][Full Text] [Related]
73. [Tumor necrosis factor-α promote permeability of human umbilical vein endothelial cells via activating RhoA-ERK1/2 pathway].
Yan CH; Yu HB; Huang MF; Li J; Zhang XL; Han YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):531-7. PubMed ID: 21924080
[TBL] [Abstract][Full Text] [Related]
74. Regulation of focal adhesion kinase activation, breast cancer cell motility, and amoeboid invasion by the RhoA guanine nucleotide exchange factor Net1.
Carr HS; Zuo Y; Oh W; Frost JA
Mol Cell Biol; 2013 Jul; 33(14):2773-86. PubMed ID: 23689132
[TBL] [Abstract][Full Text] [Related]
75. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
[TBL] [Abstract][Full Text] [Related]
76. RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response.
Wang J; Liu H; Chen B; Li Q; Huang X; Wang L; Guo X; Huang Q
Cardiovasc Diabetol; 2012 Jan; 11():7. PubMed ID: 22251897
[TBL] [Abstract][Full Text] [Related]
77. Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling.
Dwyer AR; Kerkvliet CP; Krutilina RI; Playa HC; Parke DN; Thomas WA; Smeester BA; Moriarity BS; Seagroves TN; Lange CA
Mol Cancer Res; 2021 Feb; 19(2):329-345. PubMed ID: 33172975
[TBL] [Abstract][Full Text] [Related]
78. Anti-GPR56 monoclonal antibody potentiates GPR56-mediated Src-Fak signaling to modulate cell adhesion.
Chatterjee T; Zhang S; Posey TA; Jacob J; Wu L; Yu W; Francisco LE; Liu QJ; Carmon KS
J Biol Chem; 2021; 296():100261. PubMed ID: 33837725
[TBL] [Abstract][Full Text] [Related]
79. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
Hiraoka M; Nitta N; Nagai M; Shimokado K; Yoshida M
Life Sci; 2004 Jul; 75(11):1333-41. PubMed ID: 15234191
[TBL] [Abstract][Full Text] [Related]
80. Epigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma.
Hwang YS; Park KK; Chung WY
Eur J Pharmacol; 2013 Sep; 715(1-3):286-95. PubMed ID: 23707351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
